Regina Dugan, the head of Facebook Inc.’s cutting-edge hardware lab, Building 8, is stepping down after a year and a half.
NYS Entity Status
NYS Filing Date
JANUARY 29, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - EDGE TECHNOLOGY CONSULTING INC.
Around the Web
- Facebook's Head of Research Lab Is Resigning
Tuesday Oct 17, 2017
- New Amazon Echo Is Still in First Place
Wednesday Oct 25, 2017
Amazon.com Inc.’s new Echo, smaller in size and price than the original, still has its edge with Alexa, the most advanced AI voice operating system with 25,000 skills, smart home control and voice recognition.
- Special Session for Grantmakers & Consultants: Cutting Edge Issues in Leadership Transitions
By The Editors - Thursday Oct 12, 2017
In this workshop, two of the field’s foremost experts and a panel of practitioners will present the new framework for a less risky and more robust leadership succession process.
- For 18 Hours, Cabbie Sat Dead in Front Seat
By KIM BARKER - Monday Aug 14, 2017
A driver parked his taxi to take a break in SoHo. He died behind the wheel. Then, for nearly a day, New Yorkers went about their lives — just feet from his body.
- Apple expands bet on cutting edge privacy technology
Friday Jul 7, 2017
Last year, Apple Inc. kicked off a massive experiment with new privacy technology aimed at solving an increasingly thorny problem: how to build products that understand users without snooping on their activities.
- Cancer drug research moving fast in immunotherapy field
By Michelle Fay Cortez - Tuesday Sep 5, 2017
The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.